Mike is an experienced and accomplished trial lawyer, having successfully tried cases to verdict throughout the country. He has served as national, regional and state counsel in complex litigation matters, including federal and state class actions, multidistrict litigation and coordinated proceedings in state courts. Mike also has significant experience in the defense of pharmaceutical, medical device and biologic manufacturers in complex liability litigation involving regulatory and liability issues.

Mike handles a broad spectrum of civil cases, including antitrust, contract disputes, premises liability, product liability and environmental matters. He also has represented clients in numerous fire claims, including fire prevention, investigation and defense of liability actions.

In addition to his trial work, Mike counsels clients regarding document management, product labeling (including the drafting of package inserts) and other litigation-preemptive strategies.

Before joining Shook, Mike was a partner and chair of Sedgwick LLP in San Francisco. 

Representative Matters

  • Mike served as co-lead counsel in an international antitrust action defending a global manufacturer of TFT LCD products in the United States, the European Union, Japan, Korea, Taiwan and Canada. The domestic litigation includes 143 consolidated civil class actions and investigations by the U.S. Department of Justice, as well as the states of California, Washington, Illinois, Missouri and Florida.
  • Mike helped generic drug manufacturer Perrigo Pharmaceuticals avoid several multimillion-dollar claims by convincing a federal court in the Northern District of California that the plaintiffs’ state-law claims were preempted by the Food, Drug and Cosmetics Act. The court’s ruling has broad implications because it was one of the first to explicitly recognize the preemptive effect of the Food and Drug Administration’s labeling requirements with respect to generic drug manufacturers, who are required to provide exactly the same labeling information used by the brand-name drug maker.

Publications and Presentations

Mike frequently lectures, and has authored numerous legal articles.